 | • レポートコード：GIR-107A14676 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、処方関節炎治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。処方関節炎治療薬の種類別市場規模（経口、局所）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・処方関節炎治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Amgen、Boehringer Ingelheim、Horizon Pharma、Novartis、Pfizer、Regeneron ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、局所 ・用途別分析2016年-2026年：病院薬局、オンライン薬局、小売薬局 ・処方関節炎治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・処方関節炎治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・処方関節炎治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・処方関節炎治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・処方関節炎治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prescription Arthritis Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prescription Arthritis Medications size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Prescription Arthritis Medications market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prescription Arthritis Medications market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Topical
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Prescription Arthritis Medications market are listed below:
Abbott
Amgen
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer
Regeneron
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Prescription Arthritis Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Arthritis Medications, with price, sales, revenue and global market share of Prescription Arthritis Medications in 2018 and 2019.
Chapter 3, the Prescription Arthritis Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Arthritis Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Prescription Arthritis Medications market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Prescription Arthritis Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Prescription Arthritis Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Arthritis Medications Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Topical
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Arthritis Medications Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Prescription Arthritis Medications Market Size & Forecast
1.4.1 Global Prescription Arthritis Medications Sales in Value (2016-2026))
1.4.2 Global Prescription Arthritis Medications Sales in Volume (2016-2026)
1.4.3 Global Prescription Arthritis Medications Price by Type (2016-2026) & (USD/Unit)
1.5 Global Prescription Arthritis Medications Production Capacity Analysis
1.5.1 Global Prescription Arthritis Medications Total Production Capacity (2016-2026)
1.5.2 Global Prescription Arthritis Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Arthritis Medications Market Drivers
1.6.2 Prescription Arthritis Medications Market Restraints
1.6.3 Prescription Arthritis Medications Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Prescription Arthritis Medications Product and Services
2.1.4 Abbott Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Prescription Arthritis Medications Product and Services
2.2.4 Amgen Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Prescription Arthritis Medications Product and Services
2.3.4 Boehringer Ingelheim Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Horizon Pharma
2.4.1 Horizon Pharma Details
2.4.2 Horizon Pharma Major Business
2.4.3 Horizon Pharma Prescription Arthritis Medications Product and Services
2.4.4 Horizon Pharma Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Prescription Arthritis Medications Product and Services
2.5.4 Novartis Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Prescription Arthritis Medications Product and Services
2.6.4 Pfizer Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Regeneron
2.7.1 Regeneron Details
2.7.2 Regeneron Major Business
2.7.3 Regeneron Prescription Arthritis Medications Product and Services
2.7.4 Regeneron Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Prescription Arthritis Medications Sales by Manufacturer
3.1 Global Prescription Arthritis Medications Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Prescription Arthritis Medications Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Prescription Arthritis Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Prescription Arthritis Medications Manufacturer Market Share
3.4.2 Top 6 Prescription Arthritis Medications Manufacturer Market Share
3.5 Global Prescription Arthritis Medications Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Prescription Arthritis Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prescription Arthritis Medications Market Size by Region
4.1.1 Global Prescription Arthritis Medications Sales in Volume by Region (2016-2026)
4.1.2 Global Prescription Arthritis Medications Revenue by Region (2016-2026)
4.2 North America Prescription Arthritis Medications Revenue (2016-2026)
4.3 Europe Prescription Arthritis Medications Revenue (2016-2026)
4.4 Asia-Pacific Prescription Arthritis Medications Revenue (2016-2026)
4.5 South America Prescription Arthritis Medications Revenue (2016-2026)
4.6 Middle East and Africa Prescription Arthritis Medications Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Prescription Arthritis Medications Sales in Volume by Type (2016-2026)
5.2 Global Prescription Arthritis Medications Revenue by Type (2016-2026)
5.3 Global Prescription Arthritis Medications Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Prescription Arthritis Medications Sales in Volume by Application (2016-2026)
6.2 Global Prescription Arthritis Medications Revenue by Application (2016-2026)
6.3 Global Prescription Arthritis Medications Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Prescription Arthritis Medications Sales by Type (2016-2026)
7.2 North America Prescription Arthritis Medications Sales by Application (2016-2026)
7.3 North America Prescription Arthritis Medications Market Size by Country
7.3.1 North America Prescription Arthritis Medications Sales in Volume by Country (2016-2026)
7.3.2 North America Prescription Arthritis Medications Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Prescription Arthritis Medications Sales by Type (2016-2026)
8.2 Europe Prescription Arthritis Medications Sales by Application (2016-2026)
8.3 Europe Prescription Arthritis Medications Market Size by Country
8.3.1 Europe Prescription Arthritis Medications Sales in Volume by Country (2016-2026)
8.3.2 Europe Prescription Arthritis Medications Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Prescription Arthritis Medications Sales by Type (2016-2026)
9.2 Asia-Pacific Prescription Arthritis Medications Sales by Application (2016-2026)
9.3 Asia-Pacific Prescription Arthritis Medications Market Size by Region
9.3.1 Asia-Pacific Prescription Arthritis Medications Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Prescription Arthritis Medications Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Prescription Arthritis Medications Sales by Type (2016-2026)
10.2 South America Prescription Arthritis Medications Sales by Application (2016-2026)
10.3 South America Prescription Arthritis Medications Market Size by Country
10.3.1 South America Prescription Arthritis Medications Sales in Volume by Country (2016-2026)
10.3.2 South America Prescription Arthritis Medications Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prescription Arthritis Medications Sales by Type (2016-2026)
11.2 Middle East & Africa Prescription Arthritis Medications Sales by Application (2016-2026)
11.3 Middle East & Africa Prescription Arthritis Medications Market Size by Country
11.3.1 Middle East & Africa Prescription Arthritis Medications Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Prescription Arthritis Medications Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Prescription Arthritis Medications Typical Distributors
12.3 Prescription Arthritis Medications Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Prescription Arthritis Medications Revenue by Type, (USD Million), 2021-2026
Table 2. Global Prescription Arthritis Medications Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Prescription Arthritis Medications Product and Services
Table 6. Abbott Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Prescription Arthritis Medications Product and Services
Table 10. Amgen Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Prescription Arthritis Medications Product and Services
Table 14. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Horizon Pharma Major Business
Table 17. Horizon Pharma Prescription Arthritis Medications Product and Services
Table 18. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Prescription Arthritis Medications Product and Services
Table 22. Novartis Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Prescription Arthritis Medications Product and Services
Table 26. Pfizer Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Regeneron Basic Information, Manufacturing Base and Competitors
Table 28. Regeneron Major Business
Table 29. Regeneron Prescription Arthritis Medications Product and Services
Table 30. Regeneron Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Prescription Arthritis Medications Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Prescription Arthritis Medications Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Prescription Arthritis Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Prescription Arthritis Medications Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Prescription Arthritis Medications Production Site of Key Manufacturer
Table 36. Prescription Arthritis Medications New Entrant and Capacity Expansion Plans
Table 37. Prescription Arthritis Medications Mergers & Acquisitions in the Past Five Years
Table 38. Global Prescription Arthritis Medications Sales by Region (2016-2021e) & (K Units)
Table 39. Global Prescription Arthritis Medications Sales by Region (2021-2026) & (K Units)
Table 40. Global Prescription Arthritis Medications Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Prescription Arthritis Medications Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Prescription Arthritis Medications Sales by Type (2016-2021e) & (K Units)
Table 43. Global Prescription Arthritis Medications Sales by Type (2021-2026) & (K Units)
Table 44. Global Prescription Arthritis Medications Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Prescription Arthritis Medications Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Prescription Arthritis Medications Price by Type (2016-2021e) & (USD/Unit)
Table 47. Global Prescription Arthritis Medications Price by Type (2021-2026) & (USD/Unit)
Table 48. Global Prescription Arthritis Medications Sales by Application (2016-2021e) & (K Units)
Table 49. Global Prescription Arthritis Medications Sales by Application (2021-2026) & (K Units)
Table 50. Global Prescription Arthritis Medications Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Prescription Arthritis Medications Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Prescription Arthritis Medications Price by Application (2016-2021e) & (USD/Unit)
Table 53. Global Prescription Arthritis Medications Price by Application (2021-2026) & (USD/Unit)
Table 54. North America Prescription Arthritis Medications Sales by Country (2016-2021e) & (K Units)
Table 55. North America Prescription Arthritis Medications Sales by Country (2021-2026) & (K Units)
Table 56. North America Prescription Arthritis Medications Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Prescription Arthritis Medications Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Prescription Arthritis Medications Sales by Type (2016-2021e) & (K Units)
Table 59. North America Prescription Arthritis Medications Sales by Type (2021-2026) & (K Units)
Table 60. North America Prescription Arthritis Medications Sales by Application (2016-2021e) & (K Units)
Table 61. North America Prescription Arthritis Medications Sales by Application (2021-2026) & (K Units)
Table 62. Europe Prescription Arthritis Medications Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Prescription Arthritis Medications Sales by Country (2021-2026) & (K Units)
Table 64. Europe Prescription Arthritis Medications Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Prescription Arthritis Medications Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Prescription Arthritis Medications Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Prescription Arthritis Medications Sales by Type (2021-2026) & (K Units)
Table 68. Europe Prescription Arthritis Medications Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Prescription Arthritis Medications Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Prescription Arthritis Medications Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Prescription Arthritis Medications Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Prescription Arthritis Medications Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Prescription Arthritis Medications Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Prescription Arthritis Medications Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Prescription Arthritis Medications Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Prescription Arthritis Medications Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Prescription Arthritis Medications Sales by Application (2021-2026) & (K Units)
Table 78. South America Prescription Arthritis Medications Sales by Country (2016-2021e) & (K Units)
Table 79. South America Prescription Arthritis Medications Sales by Country (2021-2026) & (K Units)
Table 80. South America Prescription Arthritis Medications Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Prescription Arthritis Medications Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Prescription Arthritis Medications Sales by Type (2016-2021e) & (K Units)
Table 83. South America Prescription Arthritis Medications Sales by Type (2021-2026) & (K Units)
Table 84. South America Prescription Arthritis Medications Sales by Application (2016-2021e) & (K Units)
Table 85. South America Prescription Arthritis Medications Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Prescription Arthritis Medications Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Prescription Arthritis Medications Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Prescription Arthritis Medications Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Prescription Arthritis Medications Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Prescription Arthritis Medications Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Prescription Arthritis Medications Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Prescription Arthritis Medications Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Prescription Arthritis Medications Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Prescription Arthritis Medications Typical Distributors
Table 97. Prescription Arthritis Medications Typical Customers
List of Figures
Figure 1. Prescription Arthritis Medications Picture
Figure 2. Global Prescription Arthritis Medications Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Topical
Figure 5. Global Prescription Arthritis Medications Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacies
Figure 7. Online Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Global Prescription Arthritis Medications Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Prescription Arthritis Medications Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Prescription Arthritis Medications Sales (2016-2026) & (K Units)
Figure 12. Global Prescription Arthritis Medications Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Prescription Arthritis Medications Production Capacity (2016-2026) & (K Units)
Figure 14. Global Prescription Arthritis Medications Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Prescription Arthritis Medications Market Drivers
Figure 16. Prescription Arthritis Medications Market Restraints
Figure 17. Prescription Arthritis Medications Market Trends
Figure 18. Global Prescription Arthritis Medications Sales Market Share by Manufacturer in 2020
Figure 19. Global Prescription Arthritis Medications Revenue Market Share by Manufacturer in 2020
Figure 20. Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Prescription Arthritis Medications Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Prescription Arthritis Medications Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Prescription Arthritis Medications Sales Market Share by Region (2016-2026)
Figure 24. Global Prescription Arthritis Medications Revenue Market Share by Region (2016-2026)
Figure 25. North America Prescription Arthritis Medications Revenue (2016-2026) & (USD Million)
Figure 26. Europe Prescription Arthritis Medications Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Prescription Arthritis Medications Revenue (2016-2026) & (USD Million)
Figure 28. South America Prescription Arthritis Medications Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Prescription Arthritis Medications Revenue (2016-2026) & (USD Million)
Figure 30. Global Prescription Arthritis Medications Sales Market Share by Type (2016-2026)
Figure 31. Global Prescription Arthritis Medications Revenue Market Share by Type (2016-2026)
Figure 32. Global Prescription Arthritis Medications Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Prescription Arthritis Medications Sales Market Share by Application (2016-2026)
Figure 34. Global Prescription Arthritis Medications Revenue Market Share by Application (2016-2026)
Figure 35. Global Prescription Arthritis Medications Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Prescription Arthritis Medications Sales Market Share by Type (2016-2026)
Figure 37. North America Prescription Arthritis Medications Sales Market Share by Application (2016-2026)
Figure 38. North America Prescription Arthritis Medications Sales Market Share by Country (2016-2026)
Figure 39. North America Prescription Arthritis Medications Revenue Market Share by Country (2016-2026)
Figure 40. United States Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Prescription Arthritis Medications Sales Market Share by Type (2016-2026)
Figure 44. Europe Prescription Arthritis Medications Sales Market Share by Application (2016-2026)
Figure 45. Europe Prescription Arthritis Medications Sales Market Share by Country (2016-2026)
Figure 46. Europe Prescription Arthritis Medications Revenue Market Share by Country (2016-2026)
Figure 47. Germany Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Prescription Arthritis Medications Revenue Market Share by Region (2016-2026)
Figure 56. China Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Prescription Arthritis Medications Sales Market Share by Type (2016-2026)
Figure 63. South America Prescription Arthritis Medications Sales Market Share by Application (2016-2026)
Figure 64. South America Prescription Arthritis Medications Sales Market Share by Country (2016-2026)
Figure 65. South America Prescription Arthritis Medications Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Prescription Arthritis Medications Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Prescription Arthritis Medications Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の処方関節炎薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms. Scope of the Report: The worldwide market for Prescription Arthritis Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$…- 世界の処方皮膚科薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Scope of the Report: The worldwide market for Prescription Dermatological Medications is expected to grow at a CAGR …
- 世界の皮膚疾患薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Scope of the Report: The worldwide market for Dermatological Disorders Medications is expected to grow at a CAGR of …
- 世界の皮膚疾患薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Scope of the Report: The worldwide market for Dermatological Disorders Medications is expected to grow at a CAGR of …
- 世界の処方胃腸用薬品市場 2021：企業別、地域別、種類・用途別 The Prescription Gastrointestinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…